Literature DB >> 18362724

An experimental model of traumatic nasoethmoidal cerebrospinal fluid fistula.

Galip Zihni Sanus1, Fatma Ozlen, Huseyin Biceroglu, Cihan Isler, Taner Tanriverdi, Ahmet Bas, Mehmet Sait Albayram, Mehmet Yasar Kaynar.   

Abstract

Cerebrospinal fluid fistula secondary to head trauma is a potentially dangerous problem and precise localization and radical treatment is mandatory. The diagnostic technique is either computed tomography cisternography or MR cisternography. For evaluating the safety of diagnostic modalities and efficacy of treatment especially in terms of surgery, animal studies demonstrating traumatic cerebrospinal fistula model are indispensable not only for neurosurgeons but also for neuroradiologists. The authors in this paper describe a traumatic cerebrospinal fistula in an animal model using rabbits. The cerebrospinal fluid leakage was demonstrated successfully in all eight rabbits and was verified by computed tomography cisternography. The results led us to conclude that rabbit model of traumatic cerebrospinal fluid fistula is safe and has low mortality and morbidity rates. Further studies including larger number of animals should be considered in order to verify safety more accurately.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362724     DOI: 10.1097/SCS.0b013e3181506477

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  2 in total

1.  The contribution of 3D-CISS and contrast-enhanced MR cisternography in detecting cerebrospinal fluid leak in patients with rhinorrhoea.

Authors:  O Algin; B Hakyemez; G Gokalp; T Ozcan; E Korfali; M Parlak
Journal:  Br J Radiol       Date:  2009-09-01       Impact factor: 3.039

2.  Intrathecal gadolinium-enhanced MR cisternography in patients with otorhinorrhea: 10-year experience of a tertiary referral center.

Authors:  Sebahat Nacar Dogan; Osman Kizilkilic; Burak Kocak; Cihan Isler; Civan Islak; Naci Kocer
Journal:  Neuroradiology       Date:  2018-03-23       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.